(Q40916302)

24 September 2017

1 reference

title

Gene therapy for cancer: what have we done and where are we going? (English)

1 reference

24 September 2017

0 references

Roth JA

1

1 reference

24 September 2017

Cristiano RJ

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Journal of the National Cancer Institute

24 September 2017

published in

1 reference

24 September 2017

volume

89

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

21-39

1 reference

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Transfer of genes to humans: early lessons and obstacles to success

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Strategies for cancer gene therapy using adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Molecular characterization of defective antigen processing in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Molecular themes in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

How does p21ras transform cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Antisense inhibition of ras p21 expression that is sensitive to a point mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Intracellular antibodies: development and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Assessment of recombinant adenoviral vectors for hepatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Adenovirus and adeno-associated virus mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Herpes simplex virus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Gene therapy and viral vaccination: the interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Transferrin-polycation conjugates as carriers for DNA uptake into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Targeted delivery of antisense oligonucleotides by molecular conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Evaluation of Relative Promoter Strength in Primary Hepatocytes Using Optimized Lipofection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Ex vivo expansion and selection of retrovirally transduced bone marrow: an efficient methodology for gene-transfer to murine lympho-haemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Combination gene therapy for liver metastasis of colon carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Role of early genes in pathogenesis of adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Role of early region 3 (E3) in pathogenesis of adenovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Aerosol gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.1.21

https://api.fatcat.wiki/v0/release/qfphpy7cujdcdkd5c4expru4oe

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_qfphpy7cujdcdkd5c4expru4oe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qfphpy7cujdcdkd5c4expru4oe

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/qfphpy7cujdcdkd5c4expru4oe

1 reference